Top Markets
Coin of the day
BioNexus Gene Lab Corporation BioNexus Gene Lab Corporation

BioNexus Gene Lab Corporation

BGLC
Rang in aandelen #18727
BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on... BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on developing and commercializing molecular diagnostic tests for the early detection of diseases and personalized health management primarily in Malaysia. Its non-invasive blood tests are used to analyze changes in ribonucleic acid for the detection of Covid-19, Dengue, human immunodeficiency virus, human papillomavirus, and the risk potentiality of cancers diseases. BioNexus Gene Lab Corporation was incorporated in 2017 and is based in Kuala Lumpur, Malaysia with an additional office in Sheridan, Wyoming.
Aandeelprijs
$2.35
Marktkapitalisatie
$4.22M
Verandering (1 dag)
-5.69%
Verandering (1 jaar)
838.98%
Land
MY
Handel BioNexus Gene Lab Corporation (BGLC)

Categorie

P/B-ratio voor BioNexus Gene Lab Corporation (BGLC)
P/B-ratio op March 2026 TTM: 0.59
Volgens de meest recente financiële rapporten en aandelenkoers van BioNexus Gene Lab Corporation is de huidige P/B-ratio (TTM) 0.59. Eind 2023 had het bedrijf een P/B-ratio van 0.95.
P/B-ratiohistoriek voor BioNexus Gene Lab Corporation van 2016 tot 2026
P/B-ratio aan het einde van elk jaar
Jaar P/B-ratio Wijzigen
2026 (TTM) 0.59 -1.60%
2024 0.60 -36.56%
2023 0.95 -96.17%
2022 24.65 -51.50%
2021 50.81 49.46%
2020 34.00 -79.93%
2019 169.36 76.55%
2018 95.93 -94.47%
2017 1.74K -101.39%
2016 -125.28K 0.00%
P/B-ratio voor vergelijkbare bedrijven of concurrenten
Bedrijf P/B-ratio Verschil in P/B-ratio Land
3.2693 453.74%
US
2.522 327.17%
US
28.6291 4,749.10%
US
3.6303 514.89%
CN
4.5682 673.75%
US